Menu

Magnesium Ascorbyl Phosphate

Also known as: MAP

A vitamin C derivative whose delivery-system research cannot establish identical results for an ordinary serum.

Pastel illustration of powder and a watery emulsion dish
Editorial illustration

Magnesium ascorbyl phosphate is a vitamin C derivative used in skincare, not a magnesium supplement. Laboratory research and a clinical delivery-system study offer pigmentation-related signals, but those findings are tied to specific preparations. They do not establish that all MAP creams reliably treat melasma or match plain vitamin C.1, 2

  • A topical vitamin C derivative, not an oral magnesium dose.1
  • The 2022 study compared ethosomal and niosomal MAP gels.1
  • The cited 2019 pigmentation mechanism work used cells.2

What is Magnesium Ascorbyl Phosphate?

MAP combines ascorbate-related chemistry with a phosphate group and magnesium salt context. It is chosen for formulation reasons, but delivery to skin remains part of the clinical question. A specialized vesicular gel is an intervention in its own right, not simply a generic serum containing the same molecule.1

Where it comes from

Natural sources

  • Vitamin C and magnesium occur in nutrition, but their presence in this name does not make the topical derivative a food.

How it's made

Manufactured and purified vitamin C derivative.

What it does in products

  • Vitamin C derivative in cosmetic skincare
  • Ingredient investigated in pigmentation-oriented delivery systems

Benefits

Pigmentation signals in specialized formulations

limited evidence

The clinical delivery study reported changes in measured pigmentation with MAP-containing vesicular gels.1

It compared delivery systems in a split-face study rather than establishing equivalence of ordinary MAP serums to standard melasma treatments. The intervention included the carrier and gel, not MAP alone.

Antioxidant and melanogenesis mechanisms

insufficient evidence

A cell study provides a possible mechanistic explanation for pigmentation-related activity.2

Preclinical measures cannot establish the magnitude, durability or tolerability of a consumer product's effect.

Evidence scope and limitations

Topical MAP, cell mechanisms and specialized vesicular delivery gels; excludes nutritional magnesium and efficacy transfer to ordinary serums.

  • The clinical intervention includes a carrier and gel.
  • Cell findings are not human efficacy evidence.
  • Long-term comparative treatment and safety conclusions are not established by these sources.

Evidence last checked: 2026-10-01

Side effects & safety

Product irritation or intolerance (varies)A delivery study is not a comprehensive long-term allergy or safety assessment for every MAP formula.

Safety considerations

  • The cited studies do not establish a universal combination routine with hydroquinone, retinoids or exfoliating acids.
  • Not for: Pigment changes or persistent irritation should not be self-diagnosed from an ingredient claim.
1, 3

Amounts studied & product use

These figures describe research or common product use, not a personal dose or treatment recommendation.

In skincare studies and products

The 2022 paper studied optimized MAP-containing ethosomal and niosomal gels over different follow-up periods. Its results do not define an optimal percentage for an ordinary serum or a personal melasma treatment protocol.

1

Regulatory status

  • A U.S. cosmetic ingredient; the cited delivery study does not grant FDA approval to treat melasma.
  • INCI name on cosmetic labels: Magnesium Ascorbyl Phosphate.
4

The carrier is part of the treatment being studied

Ethosomes and niosomes are formulated delivery systems. Their penetration and retention properties are exactly what the study investigated, so removing the carrier from the claim changes the intervention.

A similar ingredient list is not enough to establish equal delivery or equal clinical response. The practical editorial conclusion is to retain the preparation name, population and comparator whenever discussing a result.

1

Frequently asked questions

Can MAP replace a magnesium supplement?

No. This evidence concerns a topical vitamin C derivative and does not establish nutritional magnesium delivery.1

Is MAP proven equivalent to sodium ascorbyl phosphate?

The cited MAP studies do not directly establish clinical equivalence to SAP or its acne lotion. Each derivative and intended outcome requires its own evidence.1, 2

The bottom line

MAP has formulation-specific research, not a universal melasma-treatment guarantee or an oral mineral role.

References

  1. Kandil SM, Soliman II, Diab HM et al.. Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization and clinical assessment in melasma patients. Drug Delivery (2022) · primary study · PMID 35156490; DOI 10.1080/10717544.2022.2036872
  2. Miao F, Su MY, Jiang S et al.. Intramelanocytic Acidification Plays a Role in the Antimelanogenic and Antioxidative Properties of Vitamin C and Its Derivatives. Oxidative Medicine and Cellular Longevity (2019) · primary study · PMID 31214276; DOI 10.1155/2019/2084805
  3. Allergens in Cosmetics. U.S. Food and Drug Administration · government guidance · Undated live resource; accessed October 1, 2026
  4. FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated. U.S. Food and Drug Administration (2013) · government guidance · Page updated August 3, 2013; accessed October 1, 2026

Revision history

  1. Initial AI-assisted evidence compilation with source-linked claims, formulation distinctions and explicit research limitations; not independent medical review.